158 related articles for article (PubMed ID: 386790)
21. The US Food and Drug Administration and probiotics: regulatory categorization.
Degnan FH
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
[TBL] [Abstract][Full Text] [Related]
22. Philip Morris' FDA gambit: good for public health?
Givel M
J Public Health Policy; 2005 Dec; 26(4):450-68. PubMed ID: 16392744
[TBL] [Abstract][Full Text] [Related]
23. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
24. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
25. FDA Modernization Act: implications for oncology.
Morris L
Oncology (Williston Park); 1998 Nov; 12(11A):139-41. PubMed ID: 10028506
[TBL] [Abstract][Full Text] [Related]
26. Pharmacometrics at FDA: evolution and impact on decisions.
Powell JR; Gobburu JV
Clin Pharmacol Ther; 2007 Jul; 82(1):97-102. PubMed ID: 17538553
[TBL] [Abstract][Full Text] [Related]
27. A physician's guide to information available from the FDA about new drug approvals. The ACG Committee on FDA-related matters. American College of Gastroenterology.
Hassall TH; Fredd SB
Am J Gastroenterol; 1989 Oct; 84(10):1222-6. PubMed ID: 2801669
[TBL] [Abstract][Full Text] [Related]
28. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
[TBL] [Abstract][Full Text] [Related]
29. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
30. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
[TBL] [Abstract][Full Text] [Related]
31. [State surveillance and control of food quality and safety in USA].
Berman VA
Vopr Pitan; 2003; 72(2):22-7. PubMed ID: 12924205
[TBL] [Abstract][Full Text] [Related]
32. Contraceptive development and clinical trials.
Fraser IS
Clin Reprod Fertil; 1986 Feb; 4(1):75-85. PubMed ID: 3708511
[TBL] [Abstract][Full Text] [Related]
33. Evidence used for approval of new drugs.
Botstein P
Isr J Med Sci; 1986; 22(3-4):197-200. PubMed ID: 3528042
[TBL] [Abstract][Full Text] [Related]
34. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826
[TBL] [Abstract][Full Text] [Related]
35. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
Helmanis AM
Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
[No Abstract] [Full Text] [Related]
36. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
37. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
[TBL] [Abstract][Full Text] [Related]
38. Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability date.
Food and Drug Administration, HHS
Fed Regist; 2006 Nov; 71(218):66108-9. PubMed ID: 17099971
[TBL] [Abstract][Full Text] [Related]
39. Repercussions of the Drug Price Competition and Patent Term Restoration Act of 1984.
Hogan GF
Am J Hosp Pharm; 1985 Apr; 42(4):849-51. PubMed ID: 4014238
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
Binder GM
Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
